Publications by authors named "Mark Long"

Claim this Profile
T
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.
Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi, Justine Jacobi, Atrayee Bhattarchya, Mark D Long

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity.
Yihan Zuo, David J Vohwinkel, Bowen Dong, James R McDowell, Brandon V Guzman, Mark D Long

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive tumor-immune profiling reveals mediators of paradoxical immune sensitivity in sarcomatoid renal cell carcinoma.
Nicholas J Salgia, Adil Khan, Wilhelm M Aubrecht, Gavin C Twoey, Jacky Chow, Mark D Long

Cancer Cell· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.
Justine J Jacobi, Kristine M Wadosky, Neha Jaiswal, Xiaojing Zhang, Yanqing Wang, Mark D Long, Henry W Long

Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression.
Hiroki Ozawa, Yin Wang, Henry G Withers, Naoki Haratake, Ayako Nakashoji, Mark D Long

Oncogene· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma.
Kennedy S Humphrey, Katherine J Crawford, Bharani Muppavarapu, Melanie M Mayberry, William Morris, Mark D Long

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer.
Priyanka Rajan, Robert Zollo, Yanqi Guo, Mohammed Alruwaili, Justin Zonneville, Mark Long

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational landscape of triple-negative breast cancer in African American women.
Song Yao, Lei Wei, Qiang Hu, Song Liu, Zarko Manojlovic, Mark Long, Jirong Long

Nat Genet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer.
Jessie L Chiello, Nijamuddin Shaikh, Justine Jacobi, Nicole Gaulin, Gabriel Santos, Mark D Long

Mol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible therapeutic resistance in mutant lung cancer caused by loss induced lineage plasticity.
Letian Zhang, Meenalakshmi Chinnam, Bradley Balk, Xiaojing Zhang, Yanqing Wang, Mark Long

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.
Keisuke Shigeta, Tatsuaki Daimon, Hiroshi Hongo, Sheng-Yu Ku, Hiroki Ozawa, Mark D Long

JCI Insight· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.
Wenyu Shi, Zijun Y Xu-Monette, Youchao Jia, Alexandar Tzankov, Heounjeong Go, Mark Long

Blood Cancer J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma.
Katherine J Crawford, Kennedy S Humphrey, Eduardo Cortes, Jianxin Wang, Vishnu Kumarasamy, Mark D Long

Mol Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer.
Priyanka Rajan, Robert Zollo, Yanqi Guo, Mohammed Alruwaili, Justin Zonneville, Mark Long

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors.
Henry G Withers, Junko Matsuzaki, Mark Long, Spencer R Rosario, Thinle Chodon

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of DNA methylation in breast tumour subtypes with parity and breastfeeding in a cohort of 1459 Black women: implications for public health.
Christine B Ambrosone, Song Yao, Mark D Long, Chunyu Liu, Jianhong Chen

BMJ Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.
Yuhao Shi, Amber McKenery, Melissa Dolan, Michalis Mastri, James W Hill, Mark Long

EMBO Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy.
Ryutaro Kajihara, Mark D Long, Toshifumi Hoki, Hongbin Chen, Takayoshi Yamauchi

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.
Ken Young, Wen-Yu Shi, Zijun Xu-Monette, Youchao Jia, Alexandar Tzankov, Mark Long

Res Sq· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer.
Spencer R Rosario, Mark D Long, Shanmuga Chilakapati, Eduardo Cortes Gomez, Sebastiano Battaglia

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs.
Bowen Dong, Nataša Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Mark D Long

Cancer Immunol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten challenges and opportunities in computational immuno-oncology.
Riyue Bao, Alan Hutson, Anant Madabhushi, Vanessa D Jonsson, Spencer R Rosario, Mark Long

J Immunother Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma.
Hirohito Ishigaki, Takayoshi Yamauchi, Mark D Long, Toshifumi Hoki, Yuta Yamamoto

Cancer Res Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer.
Sheng-Yu Ku, Yanqing Wang, Maria Mica Garcia, Yasutaka Yamada, Kei Mizuno, Mark D Long

J Clin Invest· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling.
Melissa Dolan, Yuhao Shi, Michalis Mastri, Mark D Long, Amber McKenery

Mol Cancer Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis